Longevity
  • News
  • Investment
  • Research
  • Lifestyle
  • Videos

News

  • Home
  • Biotech
  • Investment
  • Diagnostics
  • Agetech
  • Supplements
  • Innovation
  • AI/Digital
  • Economy

Investment

  • Investment portal
  • Investment portal login
  • Register as an investor
  • Raise finance
  • Team

Research

  • All reports
  • Upcoming reports
  • Biological age diagnostics
  • Longevity supplements
  • Aging in place
  • Senotherapeutics

Lifestyle

  • Home
  • Supplements
  • Self-testing
  • Exercise
  • Nutrition
  • Tech
  • Mental wellness
  • Product reviews

More

  • About us
  • Contact
  • Features

News

  • Home
  • Biotech
  • Investment
  • Diagnostics
  • Agetech
  • Supplements
  • Innovation
  • AI/Digital
  • Economy

Yamanaka factors

Yamanaka factors Yamanaka factors – four factors that could changing aging research, our biological age and life itself. The Yamanaka …

Continue reading “Yamanaka factors”

Posted on May 24, 2022May 24, 2022

Rejuvenating human beings: the rise of cellular reprogramming

Cellular reprogramming is on the up as a growing number of companies race to develop therapies for rejuvenating human beings. …

Continue reading “Rejuvenating human beings: the rise of cellular reprogramming”

Posted on May 10, 2022May 16, 2022

Reversal of aging by partial cellular reprogramming

Partial cellular reprogramming by expression of reprogramming factors can restore youthful epigenetic signatures to aging cells and delay aging phenotypes. …

Continue reading “Reversal of aging by partial cellular reprogramming”

Posted on April 28, 2022May 5, 2022

YouthBio CEO: The time is right to develop epigenetic reprogramming therapies

Yuri Deigin hopes that a gene therapy for epigenetic reprogramming will be in clinical trials within five years. Earlier this …

Continue reading “YouthBio CEO: The time is right to develop epigenetic reprogramming therapies”

Posted on April 27, 2022April 27, 2022

Japan university tackles aging with transplanted pluripotent stem cells

Yamanaka factors-derived IPS cells demonstrate success in human clinical trial. A research team from Osaka University in Japan has concluded …

Continue reading “Japan university tackles aging with transplanted pluripotent stem cells”

Posted on April 26, 2022April 28, 2022

Skin data innovator announces residency at JLABS @ Shanghai

Following the international expansion in South Korea, Vietnam and Indonesia, HautAI skin aging tech now enters the Chinese market. Estonia-based …

Continue reading “Skin data innovator announces residency at JLABS @ Shanghai”

Posted on April 15, 2022April 27, 2022

YouthBio Therapeutics: New epigenetic rejuvenation startup emerges from stealth

Longevity biotech targets rejuvenation with gene therapies and partial epigenetic reprogramming by Yamanaka factors. Seattle-based longevity biotech YouthBio Therapeutics has …

Continue reading “YouthBio Therapeutics: New epigenetic rejuvenation startup emerges from stealth”

Posted on April 15, 2022April 26, 2022

James Peyer on breaking the geroscience dam

Ahead of the fourth annual Longevity Leaders World Congress, Cambrian’s James Peyer talks stepping stones and silver bullets in geroscience …

Continue reading “James Peyer on breaking the geroscience dam”

Posted on April 8, 2022May 12, 2022

Research reverses aging in human skin cells by 30 years

Head of Altos Labs Cambridge Institute hails “exciting implications” for aging research after cellular reprogramming success with Yamanaka factors. Can …

Continue reading “Research reverses aging in human skin cells by 30 years”

Posts navigation

Page 1 Page 2 … Page 4 Next page

Find us here ...

Subscribe to our newsletter

News

  • Home
  • Biotech
  • Investment
  • Diagnostics
  • Agetech
  • Supplements
  • Innovation
  • AI/Digital
  • Economy

Investment

  • Investment portal
  • Investment portal login
  • Register as an investor
  • Raise finance
  • Team

Research

  • All reports
  • Upcoming reports
  • Biological age diagnostics
  • Longevity supplements
  • Aging in place
  • Senotherapeutics

Lifestyle

  • Home
  • Supplements
  • Self-testing
  • Exercise
  • Nutrition
  • Tech
  • Mental wellness
  • Product reviews

More

  • About us
  • Contact
  • Features
  • Editorial Policy
  • Privacy Policy
  • Cookie Policy
  • Conditions of Business
  • Terms and Conditions
  • Copyright Policy
© Copyright 2022 FIRST LONGEVITY Limited. All rights reserved. FIRST LONGEVITY
The information included in this website is for informational purposes only: its purpose is to promote a broad consumer understanding and knowledge of various health topics. It is not intended to be a substitute for professional medical advice, diagnosis or treatment. Always seek the advice of your physician or other qualified health care provider with any questions you may have regarding a medical condition or treatment and before undertaking a new health care regimen, and never disregard professional medical advice or delay in seeking it because of something you have read on this website.